Clinical Trials Browser

Immunomodulating Agents × Clear all

NCT05828459 2025-03-20

First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors

Phase 1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT01827137 2024-09-19

WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation

Phase 1/2 Completed

20 enrolled 9 charts

GenitourinaryPlasma cell

Multiple Myeloma, Wilms Tumor

NCT03530215 2023-04-13

EROCA

500,000 enrolled

Heart Diseases, Neoplasms, Cardiotoxicity

NCT04696250 2021-01-06

AVATAR

5,000,000 enrolled

Neoplasms